Back

Medscape, LLC

  • Immune Checkpoint Inhibitors
  • Immunotherapy

Collaborative Excellence in Cancer Care: A Multidisciplinary Approach to Integrating Subcutaneous Immunotherapy

The goal of this activity is for learners to be better able to integrate subcutaneous (SC) immune checkpoint inhibitors into cancer care by identifying suitable individuals for this therapy through the application of current clinical evidence, shared decision-making, and utilizing a multidisciplinary team approach.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Jun 24, 2026
  • Last day to claim credit
    Jun 25, 2027 8 months left